Monkeypox is a viral zoonotic disease that spreads from animals to humans. First discovered in 1958 in monkeys used for research, it got its name from these initial cases. The disease was later identified in humans in 1970 in the Democratic Republic of the Congo. While it primarily occurs in central and western African countries, recent outbreaks in non-endemic regions have raised global health concerns.
Monkeypox virus is transmitted to humans through direct contact with the blood, bodily fluids, or skin lesions of infected animals, mainly rodents and primates. Human-to-human transmission occurs through close contact with an infected person or contact with contaminated materials such as bedding or clothing.
The symptoms of Monkeypox are similar to, but milder than, those of smallpox. After an incubation period of 6 to 13 days, the disease typically begins with fever, headache, muscle aches, and fatigue. This is followed by a rash that starts on the face and spreads to other parts of the body. The rash evolves from macules (flat, discolored spots) to papules (raised bumps), vesicles (fluid-filled blisters), and pustules (pus-filled lesions), eventually crusting over and falling off. Lymphadenopathy (swelling of the lymph nodes) is a key distinguishing feature of Monkeypox compared to smallpox.
Monkeypox is diagnosed through laboratory testing, including polymerase chain reaction (PCR) tests to detect viral DNA from skin lesions or other samples.
Preventing Monkeypox involves several strategies:
In the current outbreak, more than 15,600 cases and 537 deaths have been reported, with the DRC accounting for about 96 percent of the cases. Twelve other African countries have also reported cases, some for the first time.
The World Health Organization (WHO) has declared the Monkeypox outbreak in the Democratic Republic of the Congo (DRC) and a few other African nations a Public Health Emergency of International Concern (PHEIC). A PHEIC is the highest level of alarm issued by the WHO, aimed at mobilizing international attention and resources to address acute public health risks. This declaration facilitates global coordination, funding, and acceleration of vaccine and treatment development.
Monkeypox, while less severe than smallpox, remains a significant public health challenge, particularly in regions with limited healthcare infrastructure. Awareness and preparedness are crucial for managing and preventing future outbreaks.